Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Sumitomo Mitsui Financial
SMFG
$165B
| $211K | ﹤0.01% |
30,728
-713,457
| -96% | -$4.87M |
|
|
CLVS
5027
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $211K | ﹤0.01% |
53,700
+5,700
| +12% | +$46.1K |
|
5028
PUT
Precigen
PGEN
$2.18B
| $210K | ﹤0.01% |
36,700
+4,000
| +12% | +$27.2K |
|
5029
Invesco Pharmaceuticals ETF
PJP
$444M
| $210K | ﹤0.01% |
3,710
+1
| +0% | +$58 |
|
|
EFT
5030
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $209K | ﹤0.01% |
15,848
+31
| +0.2% | +$413 |
|
5031
HCI Group
HCI
$2.26B
| $209K | ﹤0.01% |
4,969
-127
| -2% | -$5.23K |
|
|
HAPN
5032
Happen Inc
HAPN
$2.22B
| $209K | ﹤0.01% |
15,967
-947
| -6% | -$13.7K |
|
|
ORC
5033
Orchid Island Capital
ORC
$1.29B
| $209K | ﹤0.01% |
7,265
-2,324
| -24% | -$70.5K |
|
5034
Park Aerospace
PKE
$736M
| $209K | ﹤0.01% |
11,910
-5,062
| -30% | -$88.2K |
|
5035
Corbus Pharmaceuticals
CRBP
$164M
| $208K | ﹤0.01% |
1,427
-104
| -7% | -$18.1K |
|
|
TDAY
5036
USA Today Co
TDAY
$1.27B
| $208K | ﹤0.01% |
23,569
-51,586
| -69% | -$471K |
|
5037
Invesco New York AMT-Free Municipal Bond ETF
PZT
$138M
| $208K | ﹤0.01% |
8,190
-300
| -4% | -$7.62K |
|
|
SAND
5038
PUT
DELISTED
Sandstorm Gold
SAND
| $208K | ﹤0.01% |
36,800
+25,000
| +212% | +$152K |
|
|
NBEV
5039
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $207K | ﹤0.01% |
75,018
+67,926
| +958% | +$240K |
|
|
UNT
5040
DELISTED
UNIT Corporation
UNT
| $207K | ﹤0.01% |
61,364
-70,437
| -53% | -$347K |
|
|
CNCR
5041
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
| $206K | ﹤0.01% |
11,085
-390
| -3% | -$7.92K |
|
5042
VanEck High Yield Muni ETF
HYD
$4.43B
| $206K | ﹤0.01% |
3,205
+584
| +22% | +$37.5K |
|
5043
PUT
IMAX
IMAX
$2.62B
| $206K | ﹤0.01% |
9,400
-4,500
| -32% | -$95.5K |
|
5044
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$852M
| $206K | ﹤0.01% |
1,480
-440
| -23% | -$75.1K |
|
5045
Global X SuperDividend ETF
SDIV
$1.22B
| $205K | ﹤0.01% |
4,024
-1,363
| -25% | -$68.6K |
|
5046
BlackRock Credit Allocation Income Trust
BTZ
$931M
| $204K | ﹤0.01% |
14,976
-466
| -3% | -$6.26K |
|
5047
Evolent Health
EVH
$335M
| $204K | ﹤0.01% |
28,337
-1,125,918
| -98% | -$8.08M |
|
5048
Hyster-Yale Materials Handling
HY
$598M
| $204K | ﹤0.01% |
3,736
-148
| -4% | -$8.22K |
|
5049
Nelnet
NNI
$4.89B
| $204K | ﹤0.01% |
3,206
-2,966
| -48% | -$190K |
|
5050
PennyMac Financial
PFSI
$3.89B
| $204K | ﹤0.01% |
6,719
-25,217
| -79% | -$680K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.